What is the Impact Factor of Microbial Drug Resistance?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Microbial Drug Resistance is 1.80, ranking in quartile Q3 of Web of Science (SCIE).

Is Microbial Drug Resistance indexed in Web of Science or Scopus?

Yes, Microbial Drug Resistance is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.605 (Q2) and an H-index of 80.

Who publishes Microbial Drug Resistance and what is the Article Processing Charge (APC)?

Microbial Drug Resistance is published by Mary Ann Liebert Inc.. The estimated Article Processing Charge (APC) is approximately $3,042 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Microbial Drug Resistance?

The official ISO-4 abbreviation of Microbial Drug Resistance is "MICROB. DRUG RESIST" with common acronym "mdr". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q2SCImago #9,763Hybrid

Microbial Drug Resistance

Acronym:mdr

•

Abbreviation (ISO):MICROB. DRUG RESIST

•

Identifier (ISSN):1076-6294(Print)/1931-8448(Online)

•

Publisher:Mary Ann Liebert Inc.

Official Website Submission Portal Compare

Clarivate IF (2026)

1.8↓ -0.1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Microbial Drug Resistance

WoS Q3

Annual Impact Factor Metric

Current (2026):1.8

Scopus SJR & RankScopus Q2

0.605

#9,763

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

80 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate4.3%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

129articles/year

5.23% Gold OA•96.63% Original Research

Aims & Scope

Microbial Drug Resistance (MDR) is an international, peer-reviewed journal that covers the global spread and threat of multi-drug resistant clones of major pathogens that are widely documented in hospitals and the scientific community. The Journal addresses the serious challenges of trying to decipher the molecular mechanisms of drug resistance. MDR provides a multidisciplinary forum for peer-reviewed original publications as well as topical reviews and special reports. MDR coverage includes: Molecular biology of resistance mechanisms Virulence genes and disease Molecular epidemiology Drug design Infection control.

Topics Covered (Recognized by AI)

Biology99.7%Microbiology97.6%Genetics97.5%Chemistry96.8%Biochemistry95.8%Geology83.3%Paleontology83.3%Bacteria82%Antibiotics79.7%Gene73.9%Medicine58.3%Escherichia coli48.6%Antibiotic resistance41.3%Organic chemistry35.8%Antimicrobial29.9%DNA26.3%Genotype25.4%Staphylococcus aureus25.1%Virology23.1%Drug resistance20.6%Pathology20.5%Plasmid20.3%

Primary Research Areas

Medicine Infectious Diseases

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

INFECTIOUS DISEASES

Rank105/141

IndexSCIE

JCRSCIE2026

MICROBIOLOGY

Rank143/167

IndexSCIE

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank258/356

IndexSCIE

JCISCIE2026

INFECTIOUS DISEASES

Rank96/141

IndexSCIE

JCISCIE2026

MICROBIOLOGY

Rank123/167

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank227/356

IndexSCIE

Category	Index	Rank	Quartile
INFECTIOUS DISEASES	JCRSCIE	105/141	Q3
MICROBIOLOGY	JCRSCIE	143/167	Q4
PHARMACOLOGY & PHARMACY	JCRSCIE	258/356	Q3
INFECTIOUS DISEASES	JCISCIE	96/141	Q3
MICROBIOLOGY	JCISCIE	123/167	Q3
PHARMACOLOGY & PHARMACY	JCISCIE	227/356	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF1.8

Articles / Year64

Total Citations13

2025

IF1.9

Articles / Year54

Total Citations83

2024

IF2.3

Articles / Year54

Total Citations159

2023

IF2.6

Articles / Year81

Total Citations459

2022

IF2.706

Articles / Year98

Total Citations914

Year	Impact Factor	Articles / Year	Total Citations
2026	1.8	64	13
2025	1.9	54	83
2024	2.3	54	159
2023	2.6	81	459
2022	2.706	98	914
2021	3.431	140	1,617
2020	2.296	214	3,719
2019	2.397	207	4,094
2018	2.344	179	4,400
2017	—	138	4,130
2016	—	142	3,670
2015	—	94	2,683

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #9,763Scopus Q2SCImago Profile

Scopus Coverage:1995-2026

•

Scopus Broad Areas:Immunology and MicrobiologyMedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q2

0.605

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

1.81

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,042 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations544

3-Year Documents267

Citable Documents249

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q2

ImmunologyQ3

MicrobiologyQ3

Microbiology (medical)Q3

PharmacologyQ3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 4.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区INFECTIOUS DISEASES

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Microbial Drug Resistance (acronym: mdr, abbr: MICROB. DRUG RESIST, ISSN: 1076-6294) is a peer-reviewed international scholarly journal in the field of Medicine, published by Mary Ann Liebert Inc. in United States since 1995. The periodical holds a Journal Impact Factor (JIF) of 1.80, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.605 (Q2), an H-index of 80.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 129 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,042 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.